Creative Medical Technology Holdings, Inc.
CELZ
$2.21
$0.00-0.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00% | -- |
| Cost of Revenue | -- | -- | -- | 0.00% | -- |
| Gross Profit | -- | -- | -- | 0.00% | -- |
| SG&A Expenses | 55.80% | 8.19% | 32.30% | -0.40% | -6.10% |
| Depreciation & Amortization | 6.14% | 4.78% | 4.44% | -11.37% | 27.39% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.72% | -22.64% | 48.12% | 6.42% | -28.37% |
| Operating Income | -14.72% | 22.26% | -47.85% | -6.43% | 28.09% |
| Income Before Tax | -18.83% | 20.83% | -57.28% | -10.46% | 28.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.83% | 20.83% | -57.28% | -10.46% | 28.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.83% | 20.83% | -57.28% | -10.46% | 28.47% |
| EBIT | -14.72% | 22.26% | -47.85% | -6.43% | 28.09% |
| EBITDA | -14.96% | 22.76% | -49.00% | -6.69% | 28.93% |
| EPS Basic | 35.90% | 56.89% | -12.87% | 10.39% | 26.44% |
| Normalized Basic EPS | 35.90% | 56.89% | -12.86% | 10.39% | 26.45% |
| EPS Diluted | 35.90% | 56.89% | -12.87% | 10.39% | 26.44% |
| Normalized Diluted EPS | 35.90% | 56.89% | -12.86% | 10.39% | 26.45% |
| Average Basic Shares Outstanding | 85.34% | 83.64% | 39.35% | 23.26% | -2.73% |
| Average Diluted Shares Outstanding | 85.34% | 83.64% | 39.35% | 23.26% | -2.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |